Clinical Trial Update: Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine or Meningococcal C Conjugate Vaccine [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting on the persistence of antibody responses in children previously vaccinated with Novartis MenACWY Conjugate Vaccine or Meningococc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• MenACWY Conjugate Vaccine (Meningococcal conjugate vaccine (serogroups A, C, W, Y))
• Meningococcal C Conjugate Vaccine (Meningococcal C conjugate vaccine)

Snippet

Sponsor: Novartis Vaccines | Conditions: Meningococcal Disease | Phase 3 | Status: COMPLETED | Results posted: 2013-10-18